Novo Holdings A/S’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33.3M Buy
2,380,000
+129,700
+6% +$1.81M 2.35% 15
2025
Q1
$30.3M Buy
2,250,300
+300
+0% +$4.04K 2.31% 15
2024
Q4
$43.1M Sell
2,250,000
-135,000
-6% -$2.59M 2.61% 12
2024
Q3
$54.3M Buy
2,385,000
+385,000
+19% +$8.76M 2.69% 10
2024
Q2
$26M Buy
2,000,000
+900,000
+82% +$11.7M 1.4% 23
2024
Q1
$19.3M Buy
+1,100,000
New +$19.3M 1.33% 24